Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Myo-inositol improves fertility and metabolic health in PCOS with fewer side effects than metformin.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Testosterone therapy increases bone density in older men with low testosterone levels.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Myrtle has various health benefits and potential for medicine development.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hair loss can significantly affect a person's self-esteem and body image, especially in young people, those who value their looks highly, and women.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).